Johnson & Johnson (JNJ) Chief Financial Office Joseph Wolk says its a "little frustrating" to see its stock drop sharply even after reporting an earnings beat on the top and bottom line. The drug maker says a strong dollar will cut into revenue and profit this year. But Wolk says the company is set up for growth and some assets in the pipeline have been undervalued. He speaks on "Bloomberg Open Interest."
Bloomberg videos, provided by MT Newswires